The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Rapamycin impairs recovery from acute renal failure: role of cell-cycle arrest and apoptosis of tubular cells
Abstract
The immunosuppressive effect of rapamycin is mediated by inhibition of interleukin-2-stimulated T cell proliferation. We report for the first time that rapamycin also inhibits growth factor-induced proliferation of cultured mouse proximal tubular (MPT; IC 50∼1 ng/ml) cells and promotes apoptosis of these cells by impairing the survival effects of the same growth factors. On the basis of these in vitro data, we tested the hypothesis that rapamycin would impair recovery of renal function after ischemic acute renal failure induced in vivo by renal artery occlusion (RAO). Rats given daily injections of rapamycin or vehicle were subjected to RAO or sham surgery. Rapamycin had no effect on the glomerular filtration rate (GFR) of sham-operated animals. In rats subjected to RAO, GFR fell to comparable levels 1 day later in vehicle- and rapamycin-treated rats (0.25 ± 0.08 and 0.12 ± 0.05 ml · min−1· 300 g−1, respectively) ( P = not significant). In vehicle-treated rats subjected to RAO, GFR increased to 0.61 ± 0.08 ml · min−1· 300 g−1 on day 3 ( P < 0.02 vs. day 1) and then rose further to 0.99 ± 0.09 ml · min−1· 300 g−1 on day 4 ( P < 0.02 vs. day 3). By contrast, GFR did not improve in rapamycin-treated rats subjected to RAO over the same time period. Rapamycin also increased apoptosis of tubular cells while markedly reducing their proliferative response after RAO. Furthermore, rapamycin inhibited activation of 70-kDa S6 protein kinase (p70 S6k) in cultured MPT cells as well as in the renal tissue of rats subjected to RAO. We conclude that rapamycin severely impairs the recovery of renal function after ischemia-reperfusion injury. This effect appears to be due to the combined effects of increased tubular cell loss (via apoptosis) and profound inhibition of the regenerative response of tubular cells. These effects are likely mediated by inhibition of p70 S6k.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104
Specificity and mechanism of action of some commonly used protein kinase inhibitors
DAVIES, S. P., REDDY, H., CAIVANO, M., & COHEN, P. (2000) · Biochemical Journal · doi:10.1042/bj3510095 · Cited by 3,132
Social controls on cell survival and cell death
Raff, M. C. (1992) · Nature · doi:10.1038/356397a0 · Cited by 2,604
Chung, J., Kuo, C. J., Crabtree, G. R., & Blenis, J. (1992) · Cell · doi:10.1016/0092-8674(92)90643-q · Cited by 1,150
Rapamycin-Induced Inhibition of the 70-Kilodalton S6 Protein Kinase
Price, D. J., Grove, J. R., Calvo, V., Avruch, J., & Bierer, B. E. (1992) · Science · doi:10.1126/science.1380182 · Cited by 666
Witzgall, R., Brown, D., Schwarz, C., & Bonventre, J. V. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117214 · Cited by 603
Alessi, D. R., Kozlowski, M. T., Weng, Q.-P., Morrice, N., & Avruch, J. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70037-5 · Cited by 574
Inhibition of the immune response by rapamycin, a new antifungal antibiotic
Martel, R. R., Klicius, J., & Galet, S. (1977) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y77-007 · Cited by 463
Lieberthal, W., Triaca, V., & Levine, J. (1996) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1996.270.4.f700 · Cited by 449
Self-citationConstitutive expression of the machinery for programmed cell death.
Weil, M., Jacobson, M. D., Coles, H. S., Davies, T. J., Gardner, R. L., Raff, K. D., & Raff, M. C. (1996) · The Journal of cell biology · doi:10.1083/jcb.133.5.1053 · Cited by 383
Graded ATP depletion can cause necrosis or apoptosis of cultured mouse proximal tubular cells
Lieberthal, W., Menza, S. A., & Levine, J. S. (1998) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1998.274.2.f315 · Cited by 377
Self-citationRegulation of the p70 S6 Kinase by Phosphorylation in Vivo
Weng, Q.-P., Kozlowski, M., Belham, C., Zhang, A., Comb, M. J., & Avruch, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.26.16621 · Cited by 375
Mechanism of action of the immunosuppressant rapamycin
Dumont, F. J., & Su, Q. (1995) · Life Sciences · doi:10.1016/0024-3205(95)02233-3 · Cited by 358
p70s6k function is essential for G1 progression
Lane, H. A., Fernandez, A., Lamb, N. J. C., & Thomas, G. (1993) · Nature · doi:10.1038/363170a0 · Cited by 345
Mechanisms of apoptosis and its potential role in renal tubular epithelial cell injury
Lieberthal, W., & Levine, J. S. (1996) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1996.271.3.f477 · Cited by 331
Self-citationThe 70 kDa S6 kinase: regulation of a kinase with multiple roles in mitogenic signalling
Chou, M. M., & Blenis, J. (1995) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(95)80064-6 · Cited by 239
Rapamycin enhances apoptosis and increases sensitivity to cisplatin in vitro.
Shi, Y., Frankel, A., Radvanyi, L. G., Penn, L. Z., Miller, R. G., & Mills, G. B. (1995) · PubMed · Cited by 225
Detection of apoptosis of immature CD4+8+ thymocytes by flow cytometry
Swat, W., Ignatowicz, L., & Kisielow, P. (1991) · Journal of Immunological Methods · doi:10.1016/0022-1759(91)90396-w · Cited by 217
Regeneration after acute tubular necrosis
Toback, F. G. (1992) · Kidney International · doi:10.1038/ki.1992.32 · Cited by 215
Necrosis and apoptosis in acute renal failure.
Lieberthal, W., Koh, J. S., & Levine, J. S. (1998) · PubMed · Cited by 212
Self-citationZhu, J., Wu, J., Frizell, E., Liu, S.-L., Bashey, R., Rubin, R., Norton, P., & Zern, M. A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70406-3 · Cited by 212
Increased membrane permeability of apoptotic thymocytes: A flow cytometric study
Ormerod, M. G., Sun, X., Snowden, R. T., Davies, R., Fearnhead, H., & Cohen, G. M. (1993) · Cytometry · doi:10.1002/cyto.990140603 · Cited by 195
Didenko, V. V., & Hornsby, P. J. (1996) · The Journal of cell biology · doi:10.1083/jcb.135.5.1369 · Cited by 189
Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506
Andoh, T. F., Burdmann, E. A., Fransechini, N., Houghton, D. C., & Bennett, W. M. (1996) · Kidney International · doi:10.1038/ki.1996.417 · Cited by 186
Morice, W. G., Brunn, G. J., Wiederrecht, G., Siekierka, J. J., & Abraham, R. T. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53755-8 · Cited by 180
Acute renal failure in the setting of bone marrow transplatation
Zager, R. A. (1994) · Kidney International · doi:10.1038/ki.1994.417 · Cited by 167
Koh, J. S., Lieberthal, W., Heydrick, S. J., & Levine, J. S. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1002 · Cited by 151
Self-citationMorice, W. G., Wiederrecht, G., Brunn, G. J., Siekierka, J. J., & Abraham, R. T. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41589-x · Cited by 139
Therapeutic use of growth factors in renal failure.
Hammerman, M. R., & Miller, S. B. (1994) · Journal of the American Society of Nephrology · doi:10.1681/asn.v511 · Cited by 136
A flow-cytometric method for the separation and quantitation of normal and apoptotic thymocytes
Sun, X., Snowden, R. T., Skilleter, D. N., et al. (1992) · Analytical Biochemistry · doi:10.1016/0003-2697(92)90251-2 · Cited by 128
Sirolimus: A new agent for prevention of renal allograft rejection
Vasquez, E. M. (2000) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/57.5.437 · Cited by 96
Role of superoxide in apoptosis induced by growth factor withdrawal
Lieberthal, W., Triaca, V., Koh, J. S., Pagano, P. J., & Levine, J. S. (1998) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1998.275.5.f691 · Cited by 88
Self-citationFrost, R. A., & Lang, C. H. (1999) · Endocrinology · doi:10.1210/endo.140.9.6998 · Cited by 85
Growth factors and cytokines in acute renal failure.
Harris, R. C. (1997) · PubMed · Cited by 45
Grammer, T. C., & Blenis, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.39.23650 · Cited by 33
The role of IGFs in catabolism
Botfield, C., Ross, R. J. M., & Hinds, C. (1997) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(97)80958-5 · Cited by 32
Liu, Y., Gorospe, M., Kokkonen, G. C., Boluyt, M. O., Younès, A., Mock, Y. D., Wang, X., Roth, G. S., & Holbrook, N. J. (1998) · Experimental Cell Research · doi:10.1006/excr.1997.3931 · Cited by 23
Powers, J. F., Tischler, A. S., & Cherington, V. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00936-7 · Cited by 16
Cited by
The tor pathway: a target for cancer therapy
Bjornsti, M.-A., & Houghton, P. J. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1362 · Cited by 1,314
An expanding role for mTOR in cancer
Guertin, D. A., & Sabatini, D. M. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.06.007 · Cited by 523
Easton, J. B., & Houghton, P. J. (2006) · Oncogene · doi:10.1038/sj.onc.1209886 · Cited by 459
Targeting mTOR signaling for cancer therapy
Huang, S. (2003) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(03)00071-7 · Cited by 436
Autophagy in acute kidney injury
Kaushal, G. P., & Shah, S. V. (2016) · Kidney International · doi:10.1016/j.kint.2015.11.021 · Cited by 389
Metadata
- Authors
- Lieberthal, W., Fuhro, R., Andry, C. C., Rennke, H., Abernathy, V. E., Koh, J. S., Valeri, R., & Levine, J. S.
- Venue
- American Journal of Physiology-Renal Physiology
- Publisher
- American Physiological Society
- Published
- 2001-10-01
- Volume
- 281
- Issue
- 4
- Pages
- F693-F706
- ISSN
- 1522-1466 (ISSN-L)
- 1931-857X
- OpenAlex
- W1906388559
- Cited by
- 270
- References
- 38
- FWCI
- 8.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.